Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content - Volume 9 Issue 3 - March 2019

  

   

Biochemical markers of oxidative stress pathways in major depression

 

Jyoti B1, Shravan Kumar2*

 

1Assistant Professor, Department of Biochemistry, Koppal Institute of Medical Sciences, Koppal, Karnataka, INDIA.

2Assistant Professor, Department of Biochemistry, ESIC Dental College, Kalaburagi, Karnataka., INDIA.

Email: skumarglb@gmail.com

 

Abstract               Context: Depression is the major disorder in present scenario which needs essential attention to prevent significant negative impact on quality of life, mortality/ morbidity and cognitive function. Major depression is characterized by decreased antioxidant status, an induction of the oxidative and nitrosative pathways. Abnormal levels of antioxidant enzymes and lipid peroxidation further substantiate the role of free radical in major depression. Objective: To evaluate and compare serum levels of oxidative stress markers and peroxidation marker and nitrosative stress pathway markers Material and methods The study included 100 subjects consisting of 50 healthy controls and 50 newly diagnosed patients of Major Depressive Disorder (MDD). Informed consent and institutional ethics committee approval was taken. Serum MDA levels was compared with parameters like SOD, Uric acid, NO, Vitamin E, Vitamin C. Clinical severity was diagnosed by trained psychiatrist using 21-items Hamilton Rating Scale for Depression (HRSD). Results: Serum MDA, NO levels were significantly (p < 0.05) increased and SOD, Vitamin E, Vitamin C, Uric acid were significantly decreased in MDD patients as compared to healthy controls. There was moderate positive correlation between MDA levels and clinical severity of depression as measured by 21-items Hamilton Rating Scale for Depression (HRSD) score which was found to be statistically significant (r = 0.317, p value = 0.025) Conclusion: The study concluded that serum MDA, SOD, Vitamin C, Vitamin E, Uric acid and NO combined together provided fairly useful index of oxidative stress and nitrosative stress pathways in MDD. Evaluation of such critical biomarkers would be useful and supportive for early diagnosis and treatment response.

Key Word: Malondialdehyde, Superoxide Dismutase, Nitric oxide, 21- item Hamilton Rating Scale for Major Depression

 

 

INTRODUCTION

Depression is the major disorder in present scenario which needs essential attention to prevent significant negative impact on quality of life, mortality/ morbidity and cognitive function. Overproduction of oxygen free radicals results in an imbalance of pro and anti oxidative processes which create a phenomenon known as oxidative stress1..Evidences have shown nitric oxide plays a prominent role in the pathogenesis of major depression. Nitric oxide modulates norepinephrine, serotonin, dopamine, and glutamate, the major neurotransmitters involved in the neurobiology of major depression [2]. In the literature there are limited and conflicting data on the relationship between lipid peroxidation and antioxidants and nitric oxide in major depressive disorders (MDD), so we took this study to evaluate and compare serum levels of oxidative stress markers and peroxidation marker and nitrosative stress pathway markers (SOD, uric acid, alfatocopherol, ascorbic acid, MDA and NO levels) and also correlated with clinical severity diagnosed by trained psychiatrist using 21-item Hamilton Rating scale for depression (HRSD). Diagnosis of major depressive disorder summarised from Diagnostic and Statistical Manual of Mental Disorders3. Assessment of severity of depression done by 21 items Hamilton Rating Scale for Depression (21 item HRSD) proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment4. Epidemiologic studies show that roughly 40– 50% of the risk for depression is genetic. This makes depression a highly heritable disorder, at least as heritable as several common complex medical conditions (type II diabetes, hypertension, asthma, certain cancers), which are often thought of as genetic5. Free radicals and reactive oxygen species attack lipids, carbohydrates, proteins, and nucleic acids and induce their oxidation may result in oxidative damage such as membrane dysfunction, protein modification, enzyme inactivation and strand breaks and modification of bases in DNA6. An antioxidant can be defined as “any substance that when present in low concentration compared to that of an oxidizable substrate significantly delays or inhibits the oxidation of that substrate” 7. There is evidence that inflammatory, oxidative, nitrosative pathways can cause neuro degeneration which progress to major depression8.A higher production of oxygen free radicals has been observed in patients with depression and anxiety, allowing a link to be established between oxidative stress and alterations in behaviour9. Malondialdehyde (MDA) is an organic compound mainly exists in the enol form, reactive oxygen species degrade polyunsaturated fatty acids, forming malondialdehyde. The production of MDA is used as a biomarker to measure the level of oxidative stress10. Nitric oxide, a mediator of inflammation causes vasodilation by relaxing vascular smooth muscle and was therefore called endothelium – derived relaxing factor11.Superoxide Dismutase (SOD) is the major intracellular antioxidant enzyme which catalytically scavenges the superoxide radical, provides defence against oxygen toxicity12.Vitamin E acts as antioxidant by scavenging molecular oxygen free radicals and has a role in cellular respiration7. Vitamin C is a potent water-soluble antioxidant vitamin in humans13.Uric acid is formed as the end product of the catabolism of other purine bases and it is a good antioxidant14. Mohammad Hasanuzzaman Shohag et al have published in the year 2012 that there was significant rise of MDA and imbalance in antioxidants in patients with Obsessive Compulsive Disorder15.

MATERIALS AND METHODS

After obtaining ethical committee clearance, a total number of 100 subjects from KIMS koppal were included in the study. Among them 50 were healthy controls and 50 were newly diagnosed cases of MDD. Inclusion criteria - cases diagnosed as major depression by trained psychiatrist using Diagnostic Statistical Manual Text Revision (DSM TR)- IV as inclusion criteria involving both sexes between the age group 18-65 years. They were compared with equal number of age and sex matched controls. Exclusion criteria - Subjects who were associated with other psychiatric disorders, metabolic disorders, autoimmune diseases, acute infection, endocrinopathies (Diabetes, Hypothyroidism, Cushing’s syndrome), malnutrition, malignancy, chronic inflammatory diseases. After taking informed consent, venous blood was collected in a sterile vacutainer under aseptic precaution from selected subjects after overnight fasting. Serum separated and analyzed for various biochemical parameters. The following parameters were estimated, malondialdehyde by Thiobarbituric acid method16, superoxide dismutase (SOD) by Marklund and Marklund method17, vitamin E by Baker and Frank method18] vitamin C by 2, 4 – dinitrophenyl hydrazine method19, nitric oxide by by Griess method20 and uric acid by enzymatic (uricase) colorimetric test is according to the recommendation by international federation of clinical chemistry in autoanalyser (ROCHE COBAS INTEGRA 400PLUS)21. Statistical analysis: Results are expressed as mean ± SD. Unpaired „t‟ test will be used. P- value < 0.05 was considered as statistically significant.Correlation between oxidative and nitrosative stress markers with clinical severity was analysed by HSRD score.

 

RESULTS

Table 1 shows comparative analysis of serum Uric acid, MDA, SOD, Vitamin E, Vitamin C, SOD activity and MDA levels between controls and MDD cases. From the table the mean levels of serum Uric acid, MDA, SOD, Vitamin E, vitamin C and NO in controls were in the range of 4.7 ±1.4mg/dl, 2.3 ±0.9nmoles/ml, 7.8 ±3.5 U/ml and 1.2 ±0.3 mg/dl, 1.1 ±0.1 mg/dl and 29.4 ± 5.6 µmol/L respectively. In MDD cases the mean levels of serum Uric acid, MDA, SOD, Vitamin E, vitamin C and NO were in the range of 3.2 ±1.2 mg/dl, 5.5 ± 0.68 mg/dl, 3.1 ±1.8 U/ml, 0.81 ± 0.2 mg/dl, 0.5 ±0.1 mg/dl, and 34.4±5.5 µmol/L respectively. Statistical analysis by unpaired t-test shows that mean levels of serum uric acid, SOD, vitamin E, vitamin C, were significantly decreased (p < 0.05) and mean level of serum MDA and NO were significantly increased in MDD cases when compared to healthy controls and are statistically highly significant (p < 0.05). Table 2 shows there was moderate positive correlation between MDA levels and clinical severity of depression as measured by 21-item Hamilton Rating Scale for Depression (HRSD) score which was found to be statistically significant (r = 0.317, P = 0.025). There was poor negative correlation between clinical severity and Uric acid and Vitamin C levels. There was no statistically significant correlation between SOD, vitamin E, NO with HSRD score.


 

Table 1: Comparison of various parameters between cases and controls

Parameter

Cases

Controls

t*

p-value

Uricacid (mg/dl)

3.2 ±1.2

4.7 ±1.4

1.71

0.001

MDA(nmoles/ml)

5.5 ± 0.68

2.3 ± 0.9

20.04

0.001

SOD(U/ml)

3.1 ±1.8

7.8 ±3.5

8.19

0.001

Vitamin E (mg/dl)

0.81 ± 0.2

1.2 ±0.3

7.48

0.001

VitaminC (mg/dl)

0.5 ±0.1

1.1 ±0.1

16.8

0.001

NO (µmol/L)

34.4 ±5.5

29.4 ± 5.6

4.48

0.001

*Independent t test

 

Table 2: Correlation between oxidative and nitrosative stress markers with clinical severity by HSRD score

Parameter

Correlation

coefficient (r)

p-value

Uric acid

-0.127

0.380

MDA

0.317

0.025

SOD

0.046

0.749

Vitamin E

0.057

0.695

Vitamin C

-0.172

0.233

NO

0.191

0.184


DISCUSSION

Major depression is a commonly occurring, seriously impairing, and often-recurrent mental disorder22, 23. The World Health Organization (WHO) ranks MDD as the fourth leading cause of disability worldwide and projects that by 2020 it will be the second leading cause owing to currently unexplained increasing prevalence in recent cohorts24. MDA, the product of lipid peroxidation reacts with lysine residues in protein to produce immunogenic molecules, which can exacerbate inflammation. The longer chain polyunsaturated fatty acids are especially potent at increasing lipid peroxidation and causing cell damage by oxidative stress which supports the need for studies assessing the therapeutic role of free radical scavengers in MDD. This is in accordance with studies of Khanzode et al and Asli Sarandal et al25, 26.

 

CONCLUSION

Major depressive disorder is a common mental disorder associated with a significant negative impact on quality of life, morbidity/mortality. The results of our study demonstrate that the oxidative stress and nitrosative stress pathway markers plays a role in MDD. Major limitation of the study is the sample size. Study with larger group may be required for further evaluation.

 

REFERENCES

  1. Piotr Gaeck et al “Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment” Pharmacological Reports, 2009; 61:436-447
  2. Ashish Phir, S.K Kulkarni, “Nitric Oxide and Major Depression” Nitric Oxide biology and chemistry official journal of the Nitric Oxide society, Publisher: Elsevier 2011; 24, (3) 125-131.
  3. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). doi:10.1176/appi.books.9780890423349
  4. Hamilton M, A rating scale for depression, J Neurol Neurosurg Psychiatry, Feb 1960; 23(1):56-62.
  5. Eric J, Nestler, Michel Barrot, Ralph J Dileone et al., “Neurobiology of depression “ March 2002; 34(1): 13-25.
  6. Noguchi N, Niki E. Chemistry of active oxygen species and antioxidants. In: Papas AM, editor. In: Antioxidant Status in Diet 1999; 3(1): 1-20.
  7. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001 Mar; 54(3):176-86.
  8. Maes M, Galeck P, Chang YS, Berk M. A review on the oxidative and nitrosative pathways in major depression and their possible contribution to the (neuro) degenaration processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry,2010; 8(3): 225-28.
  9. Bouayed, J., Rammal, H. and Soulimani, R, Oxidative stress and anxiety: Relationship and cellular pathways,Oxidative stress and cellular longevity, 2009; 2(2):63-67
  10. Malondialdehyde from Wikipedia, the free encyclopedia (Serial online) cited 1st Sept. 2009. Available from: URL:http://en.wikipedia.org/wiki/ malondialdehyde.
  11. Acute and Chronic Inflammation. In: Kumar, Abbas, Fausto, editors. Robbins and Cotran Pathologic Basis of Disease. 7th edn: Saunders; 2007: 72-73.
  12.  Frideric I. Superoxide dismutase, Ann Rev Biochem 1975; 147-159.
  13. Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JeHyuk et al. Vitamin C as an Antioxidant: Evaluation of its role in disease prevention. J Am CollNutr 2003; 22(1): 18- 35.
  14. Rodionov RN. Urate as an endogenous antioxidant. Free Radicals in Biology and Medicine 2003; 77(222): 1-11.
  15. Mohammad Hasanuzzaman Shohag et al” Serum Antioxidant Vitamins and Malondialdehyde Levels in Patients with Obsessive-Compulsive Disorder” German Journal of Psychiatry, 2012; 15(1): 10-14.
  16. Nadiger HA, Marcus SR, Chandrakala MV, Kulkarni DD. Malonyldialdehyde levels in different organs of rats subjected to acute alcohol toxicity. Indian J ClinBiochem 1996; 1:133-136.
  17. Nischal HK, Sharma MP, Goyal RK, Kaushik GG. Serum superoxide dismutase levels in diabetes mellitus with or without microangiopathic complications. JAPI 1998; 46:853-55.
  18. McMurray W, Gowenlock AH. Vitamins. In: Gowenlockedts. Varley‟s Practical Clinical Biochemistry. 6th edn. London; Heinemann Medical Books 1988; 902.
  19. Kaplan LA, Pesce AJ, Methods of Analysis Ascorbic Acid (Vitamin C). In: Clinical Chemistry. 3rd ed., Chapter 39: 786-787.
  20. Laura C Green, David A Wagner, Steven R Tannebaum. Analysis of nitrate nitrite and (15N) nitrate in biological fluids. Analytical Biochemistry Oct 1982; 126(1): 131-138.
  21. Kageyama N. A direct colorimetric determination of uric acid in serum and urine with uricase – catalase system.ClinChimActa 1971;31:421-426.
  22. Spijker J, Graaf R, Bijl R V et al. Functional disability and depression in the general population. Results from the Netherlands Mental Health survey and Incidence Study (NEMESIS). ActaPsychiatrScand 2004; 110: 208 -14.
  23. Ustun TB,Ayusu-Mateos J L, Chatterji S et al.Global burden of depressive disorders in year 2000. Br J Psychiatry 2004; 184:386-92.
  24. Murray CJ, Lopez AD. Evidence-based health policy - lessons from global Burden of disease study science 1996; 274:740-3.
  25.  Khanzode SD, Dakhale GN,Khanzode SS Oxidative damage and major depression. Redox Report 2003; 8(6):365-70.
  26. Asli Sarandal et al., Major depressive disorder is accompanied with oxidative stress: short term antidepressant treatment does not alter oxidative-antioxidant systems. Human Psychopharmacology: Clinical and Experimental, March 2007: 22(2)67-73.